New PRIMR Website Launch

By: David Grew MD MPH

Our new website features an intuitive, easy-to-use platform that allows patients to explore our educational video library.

∗ ∗ ∗

We are excited to announce the launch of the new website for PRIMR, a digital patient education company focused on providing cancer patients with comprehensive information about both standard of care treatments and groundbreaking clinical trials. Our mission is to empower patients to understand their diagnosis and treatment options before they even meet with their doctor.

Our new website features an intuitive, easy-to-use platform that allows patients to explore our educational video library. Whether you are a patient, caregiver, or healthcare professional, our videos cover a wide range of cancer-related topics to help you better understand a cancer diagnosis and available treatment options.

One of the exciting features of our new website is that patients can initiate enrollment in groundbreaking clinical trials by filling out a short form. We are proud to offer this feature, as it provides patients with an opportunity to explore cutting-edge treatments and potentially benefit from them.

We understand that a cancer diagnosis can be overwhelming and confusing, which is why we have made it our mission to provide patients with the resources they need to make informed decisions about their health. Our new website is just one of the ways we are working towards this goal.

We hope you find our new website helpful and informative. If you have any feedback or suggestions, please do not hesitate to contact us. We look forward to continuing to serve the cancer community through education and advocacy.

Other Posts

This image represents the thumbnail for the blog entitled The Untapped Potential of a Century-Old Treatment: Reviving Low-Dose Radiation Therapy for Osteoarthritis

The Untapped Potential of a Century-Old Treatment: Reviving Low-Dose Radiation Therapy for Osteoarthritis

This blog tackles the underutilized option of low-dose radiation for treating osteoarthritis in the US, a method widely ignored due to entrenched medical norms and pervasive radiophobia, despite its potential benefits and minimal side effects. It explores the history, efficacy, and misconceptions surrounding this treatment, advocating for its consideration among suitable patients who do not respond well to conventional therapies.

The thumbnail above represents the blog entitled Navigating the Evolving Landscape of Informed Consent in Clinical Trials: Draft FDA Guidance and the PRIMR Approach

Navigating the Evolving Landscape of Informed Consent in Clinical Trials: Draft FDA Guidance and the PRIMR Approach

The blog explores the transformative potential of the recent FDA guidance on informed consent processes. It highlights how PRIMR's innovative approach to patient education exemplifies the FDA's vision for a more accessible and engaging informed consent experience in clinical trials.

This image thumbnail represents the strategic partnership between UroToday and PRIMR for the blog announcement.

UroToday and PRIMR Announce Strategic Partnership to Enhance Clinical Trial Awareness

UroToday & PRIMR partner to boost clinical trial awareness in genitourinary oncology, merging UroToday's global network with PRIMR's educational content. Aimed at increasing patient enrollment, this collaboration will make trial information accessible, bridging gaps between patients & trials.